Resources

Type of publications
Regions
Diseases

5255 results found

2024 ∙ Dhamayanti, M. Andriyani, R. Moenardi, S. Karina, P. P.

Vaccine hesitancy in adolescents regarding COVID-19 vaccination: A literature review

  • Adolescents
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Alie, M. S. Abebe, G. F. Negesse, Y. Adugna, A. Girma, D.

Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis

  • Africa
  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Suares, J. E. Khan, S. Aadrika, A. Poojari, P. G. Rashid, M. Thunga, G.

Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review

  • Newborn
  • Children
  • Poliomyelitis
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wroblewski, D. Brust-Sisti, L. A. Bridgeman, M. Bridgeman, M. B.

Vaccines for Respiratory Syncytial Virus Prevention in Older Adults

  • Adults
  • Older adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Liu, J. Liu, S. Yu, S. Du, X. Hao, J. Hui, R. Buh, A. Chen, W. Chen, J.

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

  • All age groups
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Abenova, M. Shaltynov, A. Jamedinova, U. Semenova, Y.

Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0-6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies

  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Schnyder, J. L. Bache, B. E. Welkers, M. R. A. Spijker, R. Schaumburg, F. Goorhuis, A. Grobusch, M. P. de Jong, H. K.

Yellow fever breakthrough infections after yellow fever vaccination: a systematic review and meta-analysis

  • All age groups
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024

MVA-BN (‎Modified Vaccinia Ankara – Bavarian Nordic)‎ smallpox and mpox vaccine: interim guidance

  • Position paper
  • Mpox
Download:
2024 ∙ SAGE

Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024

  • Position paper
  • Mpox
Download:
2024 ∙ WHO

Summary of WHO Position Papers - Recommended Routine Immunizations for Children

  • Position paper
Download:
Loading...